AstaReal Astaxanthin Shows Promise to Inhibit NAFLD-Hepatic Steatosis
We here announce that our AstaReal® astaxanthin significantly improved NAFLD in patients with Werner syndrome, known as progeria, in a clinical study conducted by the Department of Clinical Cell Biology and Medicine, Graduate School of Medicine, Chiba University (Prof. Kotaro Yokote), which was published in the Journal of American Geriatrics Society.